Most techbio and life sciences companies do not fail on the science. They stall on six hurdles between the bench and the market.
Grant, regulatory, reimbursement, distribution, compliance and capital gaps absorb time and cash long before revenue arrives. Arc Ascend Labs closes them in the right order.
01 Grants and non-dilutive fundingMoney left on the table
NIH SBIR and STTR, ARPA-H, BARDA and state programs such as CPRIT fund this work, but aims, budgets and commercialization plans are a discipline of their own.
How we close it. A funding map by agency and mechanism, specific aims and commercialization plan support, a submission calendar and a resubmission strategy.
02 Regulatory and qualityThe wrong pathway
Claims that outrun the evidence. Submissions that slip by quarters.
How we close it. FDA and CLIA pathway options, a claims and evidence plan, and a regulatory timeline your counsel can sign off.
03 Reimbursement and payersA product nobody pays for
Clinically proven, commercially stuck: no code, no coverage, no price anchor.
How we close it. Coding and coverage roadmap, payer map, health economics evidence and a defensible price corridor.
04 Distribution and channelNo route to the buyer
The wrong distributor, the wrong first accounts, no clinical champion.
How we close it. Channel strategy, partner screening, account mapping and a key opinion leader plan.
05 Compliance and dataRules found after launch
Privacy, anti-kickback, promotional and trade rules that surface too late.
How we close it. A compliance readiness map built with your counsel: data flows, HIPAA exposure, promotional guardrails, trade screening.
06 Capital and financeA story investors cannot underwrite
Forecasts disconnected from coverage and channel. Unit economics nobody has tested.
How we close it. Revenue model tied to coverage and channel, unit economics, commercial diligence pack and data room.
The outcomeA company everyone can say yes to
Funders, regulators, payers, partners and investors see the same credible plan.
How we do it. One sequenced plan across all six areas, with owners, dates and budget.